JMUEX
Price
$28.80
Change
+$0.24 (+0.84%)
Updated
Sep 3 closing price
Net Assets
31.85B
VSMPX
Price
$347.92
Change
+$3.74 (+1.09%)
Updated
Sep 3 closing price
Net Assets
2.29T
Interact to see
Advertisement

JMUEX vs VSMPX

JMUEX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
JMUEX vs. VSMPX commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMUEX is a Buy and VSMPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.29T vs. JMUEX (31.8B). VSMPX pays higher dividends than JMUEX: VSMPX (1.04) vs JMUEX (0.49). JMUEX was incepted earlier than VSMPX: JMUEX (33 years) vs VSMPX (11 years). JMUEX (0.56) is less costly to investors than VSMPX (0.02). JMUEX is a more actively managed with annual turnover of: 39.00 vs. VSMPX (3.00). JMUEX has a lower initial minimum investment than VSMPX: JMUEX (3000000) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 18.84 vs. JMUEX (5.19). VSMPX return over 5 years is better than : 61.63 vs. JMUEX (28.41).
JMUEXVSMPXJMUEX / VSMPX
Total Expense Ratio0.560.022,800%
Annual Report Gross Expense Ratio0.560.022,800%
Fund Existence33 years11 years-
Gain YTD6.14712.45149%
Front LoadN/AN/A-
Min. Initial Investment30000001000000003%
Min. Initial Investment IRAN/AN/A-
Net Assets31.8B2.29T1%
Annual Yield % from dividends0.491.0447%
Returns for 1 year5.1918.8428%
Returns for 3 years42.9568.2863%
Returns for 5 years28.4161.6346%
Returns for 10 years111.25238.0147%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACVUX13.160.20
+1.54%
American Century International Value I
RNWCX106.131.01
+0.96%
American Funds New World R-3
CAMIX33.54N/A
N/A
Cambiar International Equity Inv
WOGSX174.21N/A
N/A
White Oak Select Growth
SMVLX102.47N/A
N/A
Smead Value Investor